TAp73 isoforms that contain the N-terminal transactivation (TA) domain function as tumor suppressors, whereas N-terminally truncated isoforms (DNp73) lack the TA domain and act as oncogenes that inhibit TAp73 and p53 in a dominant-negative fashion. The gene discussed is TP53; the disease is neoplasm.